Drs. Sara Ghandehari and Weijia Chua discuss how to best monitor patients when guidelines and protocols vary and more research is needed. Read more
Artificial Intelligence in Thoracic Radiation Oncology: Treatment, Challenges, and Future Directions
+more
In part 2 of our look at AI’s impact on radiotherapy, Grace Lee, MD, Fridolin Haugg, MSc, and Raymond H. Mak, MD, discuss how AI may be leveraged when delivering radiotherapy, including improving our ability to predict treatment response and adverse events. Read more
Artificial Intelligence in Thoracic Radiation Oncology: Patient Evaluation and Treatment Planning
+more
In part 1 of a 2-part article, Grace Lee, MD, Fridolin Haugg, MSc, and Raymond H. Mak, MD, explore the possibilities and limitations of AI applications. Read more
In an interview with ILCN, Drs. Puneeth Iyengar and Matthias Guckenberger said despite a lack of phase III data in this space, science-based recommendations are needed to optimize multimodal therapy. Read more
Dr. Narjust Florez, who is spearheading the effort at Dana Farber, says the need for research on cancer therapies for pregnant patients is urgent as both maternal age and the number of young lung cancer diagnoses are increasing. Read more
Drs. Famke L. Schneiders and Suresh Senan explore evidence that supports the use of radiotherapy to prime the immune system to maximize the benefits of immunotherapy. Read more
Dr. Cole M. Friedes and colleagues analyzed progression patterns in patients after receiving the PACIFIC regimen and showed that many patients are candidates for further ablative treatments. Read more
According to research presented during the North America Conference on Lung Cancer, moving away from pack-years of smoking history to duration of smoking history would increase the number of Black patients who qualify for screening to a rate comparable to that of white patients. Read more
Dr. Ned McNamee said the RIOMeso study is the first detailed report of real-world outcomes in Australian patients undergoing ipi + nivo treatment for pleural meso. Read more
Researchers evaluating the clinical significance of IASLC-proposed criteria found the recommendations better align with clinicopathologic risk factors and improve prognostication. Read more